Al's Comment:

 The updated guidelines  suggest more testing and get more into the genomic markers.  For Glioblastoma, the big change is that Optune (listed as "Tumor Treating Fields (TTF)") is now included in the preferred regimen for patients with a karnofsky score of 60 or more.  In the last version of the guidelines, it was just one of a few choices.  

Posted on: 05/22/2023

Updated NCCN Guidelines for Brain Tumors

You have to create a free account to access them. Go to :


Click HERE to return to brain tumor news headlines.

Our privacy / cookie policy has changed.
Click HERE to read it!